ContractSecond Registration Rights Agreement • June 27th, 2018 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • New York
This SECOND REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of June 25, 2018, is made by and among EyePoint Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and EW Healthcare Partners L.P., EW Healthcare Partners-A L.P. and each other Person identified on the signature pages hereto as an “Investor” (together with their Permitted Transferees that become party hereto, the “Investors”).
RECITALSSecond Registration Rights Agreement • January 8th, 2004 • Bakers Footwear Group Inc • Retail-shoe stores • New York
Centogene N.V. Second Registration Rights AgreementSecond Registration Rights Agreement • June 27th, 2023 • Centogene N.V. • Services-medical laboratories
SECOND REGISTRATION RIGHTS AGREEMENT, dated as of _____ 2023, between Centogene N.V., a public company with limited liability (naamloze vennootschap) incorporated under the laws of the Netherlands (the “Borrower”), and the Lender signatory hereto.
Second Registration Rights Agreement Joinder April 2, 2015Second Registration Rights Agreement • April 8th, 2015 • Dynegy Inc. • Electric services
Each of the undersigned hereby agrees as Guarantor (as defined in the Registration Rights Agreement (as amended, supplemented or joined, the “Registration Rights Agreement”), dated as of October 27, 2014, among Dynegy Inc., a Delaware corporation (as successor in interest to each of Dynegy Finance I, Inc., a Delaware corporation, and Dynegy Finance II, Inc., a Delaware corporation), and the Guarantors party thereto and Morgan Stanley & Co. LLC, Barclays Capital Inc., Credit Suisse Securities (USA) LLC, RBC Capital Markets, LLC and UBS Securities LLC, as representatives of the several Initial Purchasers listed on Schedule I thereto) to be bound by the terms and provisions attributable to a Guarantor of the Registration Rights Agreement and to assume and be bound to perform all obligations of a Guarantor thereunder. By executing and delivering this Second Registration Rights Agreement Joinder, each of the undersigned hereby becomes a party to the Registration Rights Agreement as a Guaran
Centogene N.V. Second Registration Rights Agreement October 26, 2023Second Registration Rights Agreement • October 27th, 2023 • Centogene N.V. • Services-medical laboratories • New York
SECOND REGISTRATION RIGHTS AGREEMENT, dated as of October 26, 2023, to be effective as of the Closing Date (as defined below), between Centogene N.V., a public company with limited liability (naamloze vennootschap) incorporated under the laws of the Netherlands (the “Borrower”), and the Lender signatory hereto.
AMENDMENT TO SECOND REGISTRATION RIGHTS AGREEMENTSecond Registration Rights Agreement • May 15th, 2024 • Centogene N.V. • Services-medical laboratories
THIS AMENDMENT TO SECOND REGISTRATION RIGHTS AGREEMENT (this “Amendment”) is made and entered into as of May 12, 2024, by and between Centogene N.V., a public company with limited liability (naamloze vennootschap) incorporated under the laws of the Netherlands (the “Borrower”), and Pharmaceutical Investment Company, a closed joint stock company incorporated pursuant to the laws of the Kingdom of Saudi Arabia (the “Lender”). Capitalized terms used but not otherwise defined herein shall have the respective meanings assigned to such terms in the Registration Rights Agreement.
